While not as common as other cancers in the United States, stomach cancer is one of the most challenging to treat—and therefore best managed by a multidisciplinary team of experts.

You’ll find that team at John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey. We offer therapies based on the findings of the latest medical research, as well as opportunities to participate in clinical trials evaluating promising new treatments. We do all we can to cure your cancer while maintaining your quality of life.

 

Interventional Procedures for Stomach Cancer

The interventional endoscopists at John Theurer Cancer Center are highly skilled in performing a range of techniques to stage and treat stomach cancer.

  • Visualizing the stomach. Guided by endoscopic ultrasound (EUS, an imaging method that uses high-energy sound waves), the interventional endoscopist inserts a scope through the patient’s mouth and into the stomach to look for tumors and remove a sample of tumor tissue for biopsy. The results of EUS may also be used to determine if you are eligible for stomach cancer surgery.
  • Endoscopic treatment. The interventional endoscopist can remove small superficial stomach cancers through the endoscopic (endoscopic mucosal resection, or EMR) or destroy cancerous tissue with intense heat using radiofrequency ablation.

Minimally Invasive Stomach Cancer Surgery

Our gastrointestinal cancer surgeons treat a high volume of patients and have exceptional expertise performing the full range of surgical techniques. Whenever possible, they use minimally invasive approaches, including robotic-assisted surgery, to remove stomach tumors—resulting in smaller incisions, less discomfort after surgery, and a speedier return to your normal activities.

  • Robotic gastrectomy. You may be eligible for robotic gastrectomy (partial or total removal of the stomach) if you don’t have adhesions from a prior upper digestive surgery or “bulky” cancer affecting the lymph nodes. If you do have adhesions, your surgeon may need to address them before surgery. Patients with bulky disease affecting the lymph nodes may undergo chemotherapy to shrink cancerous tissue before surgery.
  • GIST tumor surgery. Patients with gastrointestinal stromal tumors are often able to have the tumor removed through robotic-assisted surgery without extensive gastrectomy.
  • Innovative imaging. Our surgeons use Firefly technology to search for cancer cells in the lymph nodes and to assess the success of stomach cancer surgery. Using a fluorescent dye and infrared imaging, doctors can identify and remove cancer-containing lymph nodes, resulting in more accurate staging and more effective cancer control. After they remove stomach tissue and re-attach the remaining portions together, they can apply the technology to see how well two sections are joined together (anastomosis) and whether there are any “leaks” that can be repaired during the surgery—rather than waiting until complications arise later which would require a second surgery.

Innovative Chemotherapy and Immunotherapy

We offer chemotherapy combinations and targeted therapies for stomach cancer, choosing anticancer drugs based on the biology of your disease. We analyze your cancer to learn about the molecular signals driving its growth. This “precision medicine” approach ensures that you receive the therapy that is best suited for your cancer. Some patients with previously treated advanced stomach cancer may receive immunotherapy, which boosts the power of the immune system to find and destroy cancer cells. You can receive chemotherapy and immunotherapy infusion therapies in our comfortable infusion suite, which is staffed by experienced oncology nurses who monitor your health and comfort during your treatment.

Precision Radiation Therapy

If radiation therapy is part of your care, John Theurer Cancer Center provides the most advanced radiation therapy available today, featuring state-of-the-art technologies that finely target radiation to tumors. You can receive radiation that is shaped to the contours of your tumor and delivers high doses of cancer-killing energy while sparing more nearby healthy tissue than ever before.

Our Gastrointestinal Oncology Specialists


Access to Novel Clinical Trials

Clinical trials offer hope to patients with stomach cancers that have come back despite prior treatment, cannot be removed surgically, are no longer responding to treatment, or have metastasized. John Theurer Cancer Center conducts more clinical trials than any other cancer center in New Jersey. We also have a dedicated Phase I Clinical Trial Program, offering access to new treatments during their earliest stage of evaluation in patients. You may have the opportunity to participate in a clinical trial of an innovative treatment.

Gastrointestinal Cancer Clinical Trials

You may also be interested in


Researching Tomorrows Medicine

The Research Division consolidates the basic and translational research and clinical trials that are conducted at John Theurer Cancer Center and the David Joseph Jurist Research Center for Tomorrows Children.

Providing Access to the Newest Ideas and Approaches

Gastrointestinal Cancers

Digestive cancers can have wide-ranging effects on your health, nutritional status, and quality of life. Their optimal diagnosis and treatment requires a team approach, uniting experts from a variety of medical and surgical disciplines in a comprehensive, coordinated program.

Optimal Diagnosis and Treatment

Pancreatic Cancer

At John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey, patients with pancreatic cancer receive comprehensive care to treat the disease while maintaining their quality of life as much as possible.

Maintaining Your Quality of Life

Colorectal Cancer

Cancers of the colon and rectum are among the most common in the United States, diagnosed in more than 135,000 people each year.

Comprehensive Colorectal Care